Showing results (921-930 of 934) with videos related to
Sort By:
Pageof 94
Journal of Hepato-Biliary-Pancreatic Sciences|December 6, 2021
The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 systemGo Wakabayashi, Daniel Cherqui, David A Geller, et al.Journal of Hepato-Biliary-Pancreatic Sciences|December 6, 2021
Minimally invasive anatomic liver resection: Results of a survey of world expertsMamoru Morimoto, Kazuteru Monden, Taiga Wakabayashi, et al.The European Physical Journal. C, Particles and Fields|November 10, 2025
Bayesian network 3D event reconstruction in the Cygno optical TPC for dark matter direct detectionFernando Domingues Amaro, Rita Antonietti, Elisabetta Baracchini, et al.The European Physical Journal. C, Particles and Fields|October 31, 2024
Enhancing the light yield of He:CF based gaseous detectorFernando Domingues Amaro, Rita Antonietti, Elisabetta Baracchini, et al.Brain : a Journal of Neurology|July 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosisCyrus Daruwalla, Courtney Kremler, Francesco Patti, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry dataDagmawi Chilot Haile, Ibrahima Diouf, Serkan Ozakbas, et al.Journal of Neurology|April 19, 2026
Predicting disease progression in multiple sclerosis with clinically accessible information and technologyTom A N Fuchs, Menno M Schoonheim, Eva M M Strijbis, et al.NPJ Digital Medicine|July 24, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical dataAshkan Pirmani, Edward De Brouwer, Ádám Arany, et al.Journal of Neurology|February 3, 2026
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registryAmira Souissi, Francesco Patti, Tim Spelman, et al.JAMA Neurology|April 14, 2025
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple SclerosisJannis Müller, Sifat Sharmin, Johannes Lorscheider, et al.Pageof 94